ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

VQW-765

A development code.

Its studies are mostly in Phobia, Social, led by Vanda Pharmaceuticals.

Furthest: phase 3, since Oct 24, 20252 company-led studies, 1 open or runningNext primary completion: Dec 2026 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Vanda Pharmaceuticals21 open or runningphase 3since Oct 24, 2025Mar 10, 2021Dec 2026phase 3 · NCT07221578

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 10, 2021First study: phase 2 study in Phobia, SocialFirst studyNCT04800237 · 230 enrolled · United States
  2. Oct 24, 2025Phase 3 study in Phobia, SocialNCT07221578 · 500 enrolled · United States

Ahead

  1. Dec 2026Primary completion: phase 3 study in Phobia, SocialNCT07221578

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07221578Phobia, Social · United States3Active, not recruitingDec 2026500
NCT04800237Phobia, Social · United States2CompletedAug 2, 2022230

How it is read

Names in the registry

  • “VQW-765”, 2 entries

Codes read as this program: VQW765.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.